Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by ERTguyon Mar 06, 2017 3:38pm
139 Views
Post# 25939363

RE: high valuations

RE: high valuationsI see a lot of bashers putting a large emphasis on the current high valuations.  They are correct.  They fail to address the fact that the market is forward looking.  Let's use a conservative revenue of 750 million assuming now all 3 facilities are firing on all cylinders.  As per forward looking P/E ratios the market isn't really sure what it's going to look like yet especially with rec marijuana use coming online.  Eventually once the industry gets efficient costs will get pushed down tremendously.  Until that time let's say Aurora's net profit is 10% or 75 million.  In terms of EPS that works out to 25 cents a share annually.  Conservatively let's say Aurora trades as low as a 20 times earnings ratio.  That put's us at $5 right there.  Remember the average TSX P/E ratio is roughly 17, but I think it takes 5-10 years for the pot stocks to come down to TSX average as the market is transitioning from speculation to valuation as the big revenue starts coming online.  That being said even if we are trading at a 30 times P/E on very conservative numbers, that puts this stock at $7.50.  Keep in mind these targets are a few years out IMO.  Anything can happen.  Cheers
Bullboard Posts